What Does The Agreement Include?<\/p>\n
Hims & Hers stated that the Ozempic and Wegovy offerings will be made available on its platform later this month.<\/p>\n
This includes Ozempic injections in doses of 0.5 mg, 1 mg, and 2 mg and will also include Wegovy injections in doses of 1.7 mg and 2.4 mg. Wegovy pills in 1.5 mg, 4 mg, 9 mg, and 25 mg doses are also covered.<\/p>\n
Over the coming months, Hims & Hers will educate U.S. weight loss customers about their options across a wider range of FDA-approved treatments. When providers determine it is clinically appropriate, the company will help support a smooth transition to these medications, the company said.<\/p>\n
Novo\u2019s Allegations<\/p>\n
In\u00a0February this year, Novo had sued Hims & Hers,\u00a0stating<\/a> that the latter is duping consumers and healthcare professionals about the clinical benefits and safety of these unapproved drugs.<\/p>\n The U.S. Food and Drug Administration (FDA) also warned of a crackdown last week on GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs.<\/p>\n \u201cThese actions are aimed to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy.\u00a0 We take seriously any potential violations of the Federal Food, Drug, and Cosmetic Act,\u201d the agency said.<\/p>\n Subsequently, Hims & Hers announced that it would stop offering the $49 compounded version of Novo\u2019s Wegovy.<\/p>\n NVO stock<\/a> is down 23% year-to-date, while\u00a0HIMS stock<\/a> is down 33%.<\/p>\n Also See:\u00a0ImmunityBio Resubmits Supplemental Biologics License Application To FDA For Ankitva \u2014 IBRX Stock Declines Pre-Market<\/a><\/p>\n For updates and corrections, email newsroom[at]stocktwits[dot]com.<\/p>\n
![\"Add](\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/02\/1771061752_645_icon-google.2109d02c.png\"){kind=icon}
<\/a><\/p>\n